Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells
Fan, Yangwei, Ma, Ke, Jing, Jiayu, Wang, Chuying, Hu, Yuan, Shi, Yu, Li, Enxiao, Geng, QianqianVolume:
11
Year:
2020
Journal:
Journal of Cancer
DOI:
10.7150/jca.32765
File:
PDF, 2.65 MB
2020